U24DA044801
Cooperative Agreement
Overview
Grant Description
Next-generation sequencing center for ghosting hepatitis C virus: transforming community-based molecular surveillance and outbreak investigation.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Cambridge,
Massachusetts
021393583
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 07/31/22 to 07/31/23 and the total obligations have increased 556% from $500,000 to $3,279,412.
The General Hospital Corporation was awarded
HCV Ghost Sequencing Center
Cooperative Agreement U24DA044801
worth $3,279,412
from National Institute on Drug Abuse in August 2017 with work to be completed primarily in Cambridge Massachusetts United States.
The grant
has a duration of 6 years and
was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs.
The Cooperative Agreement was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Complete)
Last Modified 2/20/24
Period of Performance
8/15/17
Start Date
7/31/23
End Date
Funding Split
$3.3M
Federal Obligation
$0.0
Non-Federal Obligation
$3.3M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U24DA044801
Transaction History
Modifications to U24DA044801
Additional Detail
Award ID FAIN
U24DA044801
SAI Number
U24DA044801-1004107908
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Funding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Awardee UEI
FLJ7DQKLL226
Awardee CAGE
0ULU5
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Health and Human Services (075-0950) | Health care services | Grants, subsidies, and contributions (41.0) | $3,500,000 | 78% |
| National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) | Health research and training | Grants, subsidies, and contributions (41.0) | $998,294 | 22% |
Modified: 2/20/24